Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$662M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$116M |
| 3 |
Broadcom
AVGO
|
+$96.2M |
| 4 |
Walmart Inc
WMT
|
+$91.2M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$175M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$152M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$149M |
| 4 |
INFN
Infinera Corporation Common Stock
INFN
|
+$108M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.92% |
| 2 | Financials | 4.33% |
| 3 | Healthcare | 3.85% |
| 4 | Consumer Discretionary | 3.59% |
| 5 | Industrials | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ETNB
2276
DELISTED
89bio
ETNB
| $507K | ﹤0.01% |
+69,720
| New | +$610K |
|
2277
CALL
MetLife
MET
$60.3B
| $506K | ﹤0.01% |
6,300
-13,800
| -69% | -$1.15M |
|
2278
CALL
BP
BP
$111B
| $503K | ﹤0.01% |
14,900
-80,000
| -84% | -$2.61M |
|
2279
CALL
Weatherford International
WFRD
$6.33B
| $503K | ﹤0.01% |
+9,400
| New | +$596K |
|
2280
PUT
Agilent Technologies
A
$43.6B
| $503K | ﹤0.01% |
4,300
-3,700
| -46% | -$499K |
|
2281
TripAdvisor
TRIP
$1.19B
| $502K | ﹤0.01% |
35,452
-49,273
| -58% | -$772K |
|
2282
CALL
Manhattan Associates
MANH
$12.3B
| $502K | ﹤0.01% |
2,900
+1,700
| +142% | +$354K |
|
|
GRMN
2283
PUT
Garmin
GRMN
$55.5B
| $499K | ﹤0.01% |
+2,300
| New | +$497K |
|
2284
PUT
Dominion Energy
D
$58.7B
| $499K | ﹤0.01% |
8,900
+1,000
| +13% | +$55K |
|
2285
PUT
Carter's
CRI
$1.26B
| $499K | ﹤0.01% |
12,200
+700
| +6% | +$33.7K |
|
2286
PUT
Brown-Forman Class B
BF.B
$12.9B
| $499K | ﹤0.01% |
14,700
+500
| +4% | +$16.9K |
|
2287
Fastly Inc
FSLY
$3.71B
| $498K | ﹤0.01% |
78,668
-225,552
| -74% | -$1.88M |
|
2288
PUT
BridgeBio Pharma
BBIO
$15.9B
| $498K | ﹤0.01% |
+14,400
| New | +$486K |
|
2289
CALL
CBRE Group
CBRE
$43.7B
| $497K | ﹤0.01% |
3,800
-5,200
| -58% | -$707K |
|
2290
PUT
American Superconductor
AMSC
$1.43B
| $495K | ﹤0.01% |
27,300
+13,700
| +101% | +$342K |
|
2291
CALL
Southwest Airlines
LUV
$19.8B
| $494K | ﹤0.01% |
14,700
+800
| +6% | +$25.3K |
|
2292
CALL
Vital Farms
VITL
$472M
| $494K | ﹤0.01% |
16,200
+9,700
| +149% | +$349K |
|
2293
National Fuel Gas
NFG
$7.79B
| $491K | ﹤0.01% |
+6,198
| New | +$446K |
|
2294
Virtus Investment Partners
VRTS
$1.11B
| $491K | ﹤0.01% |
2,847
-1,786
| -39% | -$341K |
|
2295
CALL
Rapid7
RPD
$812M
| $490K | ﹤0.01% |
18,500
+13,200
| +249% | +$449K |
|
2296
PUT
Tradeweb Markets
TW
$22.8B
| $490K | ﹤0.01% |
3,300
-800
| -20% | -$106K |
|
2297
PUT
Wabtec
WAB
$50B
| $490K | ﹤0.01% |
2,700
-300
| -10% | -$57.5K |
|
2298
PUT
Equinix
EQIX
$107B
| $489K | ﹤0.01% |
+600
| New | +$539K |
|
2299
CALL
Saia
SAIA
$9.29B
| $489K | ﹤0.01% |
1,400
+800
| +133% | +$348K |
|
2300
PUT
Unum
UNM
$14B
| $489K | ﹤0.01% |
6,000
-12,500
| -68% | -$964K |
|
Similar funds
Paul Tudor Jones's Q1 2025 Portfolio in Review
As of Q1 2025, Paul Tudor Jones held 3,818 positions worth $30.1B, up 15% from $26.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Paul Tudor Jones deployed $6.13B of net new capital in Q1 2025, opening 874 new positions and adding to 1,161 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $175M trimmed.
- Paul Tudor Jones's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
- Paul Tudor Jones added most to iShares Russell 2000 ETF in Q1 2025, an estimated $662M increase.
- Paul Tudor Jones's biggest Q1 2025 reduction was iShares Bitcoin Trust, cutting an estimated $175M.
- Paul Tudor Jones fully exited Infinera Corporation Common Stock in Q1 2025, selling an estimated $108M.
- Paul Tudor Jones's ten largest holdings make up 40% of its $30.1B portfolio in Q1 2025.
- Paul Tudor Jones opened 874 new positions and closed 844 in Q1 2025.
- Paul Tudor Jones's portfolio value rose 15% quarter-over-quarter to $30.1B.
Based on Tudor Investment Corp's 13F filing for Q1 2025, filed 15 May 2025.